3 Results for "

TRK resistance mutations

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "TRK resistance mutations" in MCE Product Catalog:

Cat. No.: HY-152292
CAS No.: 2739829-00-4
Purity:  99.55%
Synonyms: NVL-520; NUV-520
Target:  

ROS Kinase

Research Areas:  

Cancer

Zidesamtinib (NVL-520) is a potent, selective, orally active and brain-penetrant inhibitor of diverse ROS1 fusions and resistance mutations, with IC50s of 0.7 and 7.9 nM for wild-type ROS1 and ROS1 G2032R, respectively, and spares TRK inhibition. Zidesamtinib can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-148811
CAS No.: 2403703-30-8
Synonyms: ICP-723
Target:  

c-Met/HGFR Trk Receptor

Research Areas:  

Cancer

Zurletrectinib is a brain-penetrant, orally active TRK inhibitor (TRKA IC50 = 0.81 nM; TRKB IC50 = 0.145 nM; TRKC IC50 = 0.184 nM). Zurletrectinib exhibits stronger activity as a consequence of its augmented binding affinity for TRK kinases. Zurletrectinib exhibits higher activity against most TRK inhibitor resistance mutations (13 out of 18 mutations). Zurletrectinib can be used for the study of glioma .
loading...
    loading...
Cat. No.: HY-150561
CAS No.: 2460924-63-2
Target:  

Trk Receptor

Research Areas:  

Cancer

Trk-IN-20 is a kind of 3-vinylindazole derivatives. Trk-IN-20 suppresses Trk kinases functions by phosphorylation inhibition of TrkA/B/C with IC50 values of 1.6 nM, 2.9 nM and 2.0 nM, respectively .
loading...
    loading...